Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shibeshih Belachew

Showing results (31-40 of 81) with videos related to

Pageof 9
Sort By:
Molecular Pharmacology|February 22, 2005
Developmental regulation of beta-carboline-induced inhibition of glycine-evoked responses depends on glycine receptor beta subunit expressionJean-Marie Mangin, Laurent Nguyen, Catherine Gougnard, et al.
Stem Cells (Dayton, Ohio)|February 15, 2011
Cdk6-dependent regulation of G(1) length controls adult neurogenesisPierre Beukelaers, Renaud Vandenbosch, Nicolas Caron, et al.
Annals of Neurology|October 3, 2014
Anti-JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathyTatiana Plavina, Meena Subramanyam, Gary Bloomgren, et al.
Multiple Sclerosis and Related Disorders|July 17, 2023
Assessing the utility of magnetic resonance imaging-based "SuStaIn" disease subtyping for precision medicine in relapsing-remitting and secondary progressive multiple sclerosisXiaotong Jiang, Changyu Shen, Bastien Caba, et al.
Journal of Medical Internet Research|November 21, 2022
Digital Devices for Assessing Motor Functions in Mobility-Impaired and Healthy Populations: Systematic Literature ReviewChristine C Guo, Patrizia Andrea Chiesa, Carl de Moor, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 31, 2017
Greater sensitivity to multiple sclerosis disability worsening and progression events using a roving versus a fixed reference value in a prospective cohort studyLudwig Kappos, Helmut Butzkueven, Heinz Wiendl, et al.
Multiple Sclerosis and Related Disorders|June 4, 2018
Natalizumab treatment shows low cumulative probabilities of confirmed disability worsening to EDSS milestones in the long-term settingMaria Trojano, Helmut Butzkueven, Ludwig Kappos, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 20, 2018
Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesionsColm Elliott, Jerry S Wolinsky, Stephen L Hauser, et al.
Gait & Posture|December 14, 2020
U-turn speed is a valid and reliable smartphone-based measure of multiple sclerosis-related gait and balance impairmentWei-Yi Cheng, Alan K Bourke, Florian Lipsmeier, et al.
Biochemical Pharmacology|February 16, 2005
Peripheral benzodiazepine receptor (PBR) ligand cytotoxicity unrelated to PBR expressionGregory Hans, Sabine Wislet-Gendebien, François Lallemend, et al.
Pageof 9

Showing results (31-40 of 81) with videos related to

Sort By:
Pageof 9
Molecular Pharmacology|February 22, 2005
Developmental regulation of beta-carboline-induced inhibition of glycine-evoked responses depends on glycine receptor beta subunit expressionJean-Marie Mangin, Laurent Nguyen, Catherine Gougnard, et al.
Stem Cells (Dayton, Ohio)|February 15, 2011
Cdk6-dependent regulation of G(1) length controls adult neurogenesisPierre Beukelaers, Renaud Vandenbosch, Nicolas Caron, et al.
Annals of Neurology|October 3, 2014
Anti-JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathyTatiana Plavina, Meena Subramanyam, Gary Bloomgren, et al.
Multiple Sclerosis and Related Disorders|July 17, 2023
Assessing the utility of magnetic resonance imaging-based "SuStaIn" disease subtyping for precision medicine in relapsing-remitting and secondary progressive multiple sclerosisXiaotong Jiang, Changyu Shen, Bastien Caba, et al.
Journal of Medical Internet Research|November 21, 2022
Digital Devices for Assessing Motor Functions in Mobility-Impaired and Healthy Populations: Systematic Literature ReviewChristine C Guo, Patrizia Andrea Chiesa, Carl de Moor, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 31, 2017
Greater sensitivity to multiple sclerosis disability worsening and progression events using a roving versus a fixed reference value in a prospective cohort studyLudwig Kappos, Helmut Butzkueven, Heinz Wiendl, et al.
Multiple Sclerosis and Related Disorders|June 4, 2018
Natalizumab treatment shows low cumulative probabilities of confirmed disability worsening to EDSS milestones in the long-term settingMaria Trojano, Helmut Butzkueven, Ludwig Kappos, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 20, 2018
Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesionsColm Elliott, Jerry S Wolinsky, Stephen L Hauser, et al.
Gait & Posture|December 14, 2020
U-turn speed is a valid and reliable smartphone-based measure of multiple sclerosis-related gait and balance impairmentWei-Yi Cheng, Alan K Bourke, Florian Lipsmeier, et al.
Biochemical Pharmacology|February 16, 2005
Peripheral benzodiazepine receptor (PBR) ligand cytotoxicity unrelated to PBR expressionGregory Hans, Sabine Wislet-Gendebien, François Lallemend, et al.
Pageof 9